Home » Authors » Cormac Sheridan

Articles by Cormac Sheridan

Swedish Discovery Firms Merge, Secure US$15.5M In Financing

Jan. 23, 2002

By Cormac Sheridan

Rhein Biotech Plans Filing This Year For Two-Dose HBV Vaccine

Jan. 16, 2002

By Cormac Sheridan

Rhein Biotech Plans Filing This Year For Two-Dose HBV Vaccine

Jan. 16, 2002

By Cormac Sheridan

ThromboGenics Raises US$12.8M For Cardio, Stem Cell Programs

May 16, 2001

By Cormac Sheridan

Genmab, Roche Collaborate To Develop Antibody Products

May 16, 2001

By Cormac Sheridan

ThromboGenics Raises US$12.8M For Cardio, Stem Cell Programs

May 16, 2001

By Cormac Sheridan

Genmab, Roche Collaborate To Develop Antibody Products

May 16, 2001

By Cormac Sheridan

NeuroSearch Pays US$3.5M In Stock For Genomics Company

March 28, 2001

By Cormac Sheridan

NeuroSearch Pays US$3.5M In Stock For Genomics Company

March 28, 2001

By Cormac Sheridan

Modex Plans To Move EPO Cell Therapy Into Phase II

March 21, 2001

By Cormac Sheridan

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 1, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for April 1, 2025.
Novo Nordisk licenses Lexicon’s preclinical obesity drug in $1B deal
BioWorld Science
As companies continually search for next-generation obesity prospects, one of the leaders in the disease space, Novo Nordisk A/S, has obtained an exclusive...
Corcept looks to NDA following strong phase III ovarian cancer data
BioWorld
Relacorilant, a cortisol modulator from Corcept Therapeutics Inc., produced new and strong phase III results in treating platinum-resistant ovarian cancer. The...
Otsuka submits first BLA to FDA for sibeprenlimab in IgAN
BioWorld
Otsuka Pharmaceutical Development & Commercialization Inc. filed its BLA with the U.S. FDA for sibeprenlimab to treat immunoglobulin A nephropathy (IgAN). The...